Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is a 20% increase over the number of companies inspected in the previous month, when five companies received five inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected period worked in the Devices sector.
There were five companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Aryzta, LLC | Food and Cosmetics | 05/01/2024 | No Action Indicated (NAI) |
Evoqua Water Technologies, LLC | Devices | 05/14/2024 | Voluntary Action Indicated (VAI) |
KPC Products, Inc. | Food and Cosmetics | 05/09/2024 | No Action Indicated (NAI) |
Modulated Imaging, Inc. | Devices | 05/07/2024 | No Action Indicated (NAI) |
Rief Enterprises, Inc. | Food and Cosmetics | 05/01/2024 | No Action Indicated (NAI) |
T & L Produce, Inc. | Food and Cosmetics | 05/01/2024 | No Action Indicated (NAI) |